Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Taysha Gene Therapies Inc (TSHA)

Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 452,924
  • Shares Outstanding, K 204,943
  • Annual Sales, $ 15,450 K
  • Annual Income, $ -111,570 K
  • EBIT $ -77 M
  • EBITDA $ -76 M
  • 60-Month Beta 0.44
  • Price/Sales 31.70
  • Price/Cash Flow N/A
  • Price/Book 4.11

Options Overview Details

View History
  • Implied Volatility 129.29% ( -46.00%)
  • Historical Volatility 134.91%
  • IV Percentile 40%
  • IV Rank 31.28%
  • IV High 404.32% on 01/17/24
  • IV Low 4.07% on 12/19/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 619
  • Volume Avg (30-Day) 220
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 3,103
  • Open Int (30-Day) 1,951

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.08
  • Number of Estimates 3
  • High Estimate -0.08
  • Low Estimate -0.09
  • Prior Year 0.35
  • Growth Rate Est. (year over year) -122.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.19 +90.76%
on 11/05/24
2.63 -13.69%
on 11/14/24
+0.28 (+14.07%)
since 10/14/24
3-Month
1.19 +90.76%
on 11/05/24
2.63 -13.69%
on 11/14/24
-0.04 (-1.73%)
since 08/14/24
52-Week
1.19 +90.76%
on 11/05/24
4.32 -47.45%
on 06/13/24
+0.94 (+70.68%)
since 11/14/23

Most Recent Stories

More News
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TSHA : 2.27 (+2.71%)
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

TSHA : 2.27 (+2.71%)
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TSHA : 2.27 (+2.71%)
Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

TSHA : 2.27 (+2.71%)
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TSHA : 2.27 (+2.71%)
3 Growth Stocks That Could Go Parabolic in 2024

These innovation-oriented companies could take flight this year.

ABCL : 2.76 (-5.48%)
CERS : 1.8000 (-3.23%)
TSHA : 2.27 (+2.71%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Taysha Gene Therapies, Inc. (NASDAQ: TSHA) for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

TSHA : 2.27 (+2.71%)
2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?

These highly volatile stocks recently rocketed higher, but what are the chances that they'll be able to provide further gains?

CGC : 3.74 (-5.08%)
TSHA : 2.27 (+2.71%)
S&P Futures Tick Lower As Investors Await Fed Rate Decision, Snap Plunges on Weak Outlook

March S&P 500 futures (ESH23) are trending down -0.41% this morning after three major U.S. benchmark indices finished the regular session higher as market participants weighed up economic data and a slew...

ESH23 : 3,957.05s (-0.09%)
GM : 57.62 (-0.16%)
PHM : 129.44 (+1.54%)
SNAP : 10.76 (-3.15%)
HUSQB.S.DX : 64.820 (+1.19%)
WDC : 63.22 (+0.78%)
EA : 164.12 (+0.86%)
AMD : 138.84 (-0.33%)
JSPR : 22.10 (-3.07%)
TSHA : 2.27 (+2.71%)
Taysha Gene Therapies (NASDAQ: TSHA) Receives $50 Million Strategic Investment From Astellas Pharma to Develop AAV-Based Gene Therapeutics

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is a biotechnology company that is focused on developing gene therapies to treat monogenic

TSHA : 2.27 (+2.71%)

Business Summary

Taysha Gene Therapies Inc. is a patient-centric gene therapy company. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company's product pipeline includes TSHA-101, TSHA-118, TSHA-102, TSHA-103 and TSHA-104...

See More

Key Turning Points

3rd Resistance Point 3.28
2nd Resistance Point 2.96
1st Resistance Point 2.61
Last Price 2.27
1st Support Level 1.94
2nd Support Level 1.62
3rd Support Level 1.27

See More

52-Week High 4.32
Fibonacci 61.8% 3.12
Fibonacci 50% 2.76
Fibonacci 38.2% 2.39
Last Price 2.27
52-Week Low 1.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar